WASHINGTON – Formal hearing proceedings regarding the proposed rescheduling of marijuana will begin on December 2, 2024 at 9:30 A.M. ET in the North Courtroom at DEA Headquarters located at 700 Army Navy Drive, Arlington, VA. This preliminary hearing will serve as a procedural day to address legal and logistical...

The U.S. Drug Enforcement Administration is committed to using every tool at its disposal to help fight the drug poisoning and overdose crisis facing America today. In February 2024, DEA issued a letter to e-commerce companies reminding them of their responsibility as regulated entities to comply with the recordkeeping, identification...

On April 3, the U.S. Drug Enforcement Administration and the Ministry of the Interior of Uruguay signed a memorandum of cooperation (MOC) to solidify cooperation between the two countries to combat the organized drug crime threat in Uruguay and the region. Held at DEA Headquarters in Arlington, Va., DEA Principal...

Albuquerque Public Schools has become a New Mexico leader in substance misuse prevention education by implementing DEA’s Operation Prevention curriculum across their school district. On March 25, the DEA El Paso Division, with the help of DEA Headquarters Community Outreach Section, and Discovery Education, trained 55 Albuquerque Public Schools (APS)...

DEA is committed to making sure patients can get the care they need in the event a doctor or medical facility is unable to provide treatment due to enforcement action against the medical provider. On October 5, 2023, DEA arrested a nurse practitioner in Buffalo, New York, on charges of...

Fentanyl is the greatest threat facing Americans today. It is a threat to our public health, our public safety, and our national security, and it is the cause of the most devastating drug crisis in United States’ history. The U.S. Drug Enforcement Administration (DEA) is committed to using every tool...

Washington, D.C. – The U.S. Drug Enforcement Administration (DEA) is focused on saving American lives by defeating the cartels responsible for bringing fentanyl into our country. The threat of fentanyl is deadlier and more pervasive than ever before. When I joined DEA in 2021, DEA laboratory testing indicated 4 out...

On July 26, 2023, DEA temporarily scheduled five synthetic benzodiazepine substances – etizolam, flualprazolam, clonazolam, flubromazolam, and diclazepam – in schedule I of the Controlled Substances Act (CSA). Individuals who handle these substances will now be subject to regulatory controls, as well as to administrative, civil, and criminal sanctions applicable...

The U.S. Drug Enforcement Administration and the U.S. Department of Homeland Security are updating the American public on the ongoing threat of illicit xylazine. In April 2023, the White House Office of National Drug Control Policy (ONDCP) designated fentanyl adulterated or associated with xylazine as an emerging threat to the...

Patients now have the ability to request their electronic prescription be transferred to another pharmacy without having to go back to their practitioner to initiate the request. This revised regulation went into effect on Monday, August 28, 2023. At a patient’s request, a DEA-registered retail pharmacy can now transfer an...